⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1773842 | 1.00 | — | — | |
| SCHEMBL9333820 | 0.72 | OR51E2 (0.59) | — | |
| SCHEMBL9307587 | 0.72 | OR51E2 (0.59) | — | |
| SCHEMBL14564211 | 0.72 | OR51E2 (0.59) | — | |
| SCHEMBL2310885 | 0.71 | — | — | |
| SCHEMBL1765577 | 0.69 | OR51E2 (1.00) | — | |
| SCHEMBL400739 | 0.69 | — | — | |
| SCHEMBL38462 | 0.69 | — | — | |
| Water SCHEMBL10757023 | 0.69 | — | — | |
| Water SCHEMBL21753470 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100261926-A1 | SURFACE-MODIFIED NANODIAMOND AND ITS PRODUCING METHOD | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-10-14 | — | — | US | claimed |
| US-4165365-A | ANTIALLERGENS ESPECIALLY FOR ASTHMA | SMITHKLINE CORPORATION (US) | 1979-08-21 | — | — | US | claimed |
| US-8410196-B2 | Surface-modified nanodiamond and its producing method | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2013-04-02 | — | — | US | disclosed |
| US-20100261926-A1 | SURFACE-MODIFIED NANODIAMOND AND ITS PRODUCING METHOD | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-10-14 | — | — | US | disclosed |
| US-4742057-A | Antiallergic thiazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-05-03 | — | — | US | disclosed |
| EP-0224919-A2 | New thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-06-10 | — | — | EP | disclosed |